singula bio ltd
singula bio ltd Company Information
Company Number
12792274
Next Accounts
May 2025
Shareholders
iiu nominees limited
ahmed
View AllGroup Structure
View All
Industry
Specialist medical practice activities
Registered Address
20 ambleside drive, headington, oxford, OX3 0AG
Website
singulabio.comsingula bio ltd Estimated Valuation
Pomanda estimates the enterprise value of SINGULA BIO LTD at £212.7k based on a Turnover of £409.7k and 0.52x industry multiple (adjusted for size and gross margin).
singula bio ltd Estimated Valuation
Pomanda estimates the enterprise value of SINGULA BIO LTD at £0 based on an EBITDA of £-367.7k and a 3.55x industry multiple (adjusted for size and gross margin).
singula bio ltd Estimated Valuation
Pomanda estimates the enterprise value of SINGULA BIO LTD at £0 based on Net Assets of £-113.3k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Singula Bio Ltd Overview
Singula Bio Ltd is a live company located in oxford, OX3 0AG with a Companies House number of 12792274. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in August 2020, it's largest shareholder is iiu nominees limited with a 50% stake. Singula Bio Ltd is a young, micro sized company, Pomanda has estimated its turnover at £409.7k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Singula Bio Ltd Health Check
Pomanda's financial health check has awarded Singula Bio Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
1 Strong
4 Regular
4 Weak
Size
annual sales of £409.7k, make it in line with the average company (£376.1k)
- Singula Bio Ltd
£376.1k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Singula Bio Ltd
- - Industry AVG
Production
with a gross margin of 54.7%, this company has a comparable cost of product (54.7%)
- Singula Bio Ltd
54.7% - Industry AVG
Profitability
an operating margin of -90.1% make it less profitable than the average company (14.3%)
- Singula Bio Ltd
14.3% - Industry AVG
Employees
with 5 employees, this is below the industry average (8)
5 - Singula Bio Ltd
8 - Industry AVG
Pay Structure
on an average salary of £30.4k, the company has an equivalent pay structure (£30.4k)
- Singula Bio Ltd
£30.4k - Industry AVG
Efficiency
resulting in sales per employee of £81.9k, this is equally as efficient (£73k)
- Singula Bio Ltd
£73k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Singula Bio Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 260 days, this is slower than average (40 days)
- Singula Bio Ltd
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Singula Bio Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (81 weeks)
4 weeks - Singula Bio Ltd
81 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 458%, this is a higher level of debt than the average (31.4%)
458% - Singula Bio Ltd
31.4% - Industry AVG
SINGULA BIO LTD financials
Singula Bio Ltd's latest turnover from August 2023 is estimated at £409.7 thousand and the company has net assets of -£113.3 thousand. According to their latest financial statements, Singula Bio Ltd has 5 employees and maintains cash reserves of £12.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2023 | Aug 2022 | Aug 2021 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | 5 | 4 | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2023 | Aug 2022 | Aug 2021 | |
|---|---|---|---|
| Tangible Assets | 829 | 2,408 | 3,987 |
| Intangible Assets | |||
| Investments & Other | |||
| Debtors (Due After 1 year) | |||
| Total Fixed Assets | 829 | 2,408 | 3,987 |
| Stock & work in progress | |||
| Trade Debtors | |||
| Group Debtors | |||
| Misc Debtors | 18,259 | 135,070 | 345,557 |
| Cash | 12,566 | 422,283 | 1,255,743 |
| misc current assets | |||
| total current assets | 30,825 | 557,353 | 1,601,300 |
| total assets | 31,654 | 559,761 | 1,605,287 |
| Bank overdraft | |||
| Bank loan | |||
| Trade Creditors | 132,276 | 194,064 | 269,711 |
| Group/Directors Accounts | |||
| other short term finances | |||
| hp & lease commitments | |||
| other current liabilities | 12,696 | 121,194 | 1,819 |
| total current liabilities | 144,972 | 315,258 | 271,530 |
| loans | |||
| hp & lease commitments | |||
| Accruals and Deferred Income | |||
| other liabilities | |||
| provisions | |||
| total long term liabilities | |||
| total liabilities | 144,972 | 315,258 | 271,530 |
| net assets | -113,318 | 244,503 | 1,333,757 |
| total shareholders funds | -113,318 | 244,503 | 1,333,757 |
| Aug 2023 | Aug 2022 | Aug 2021 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | 1,579 | 1,579 | 751 |
| Amortisation | |||
| Tax | |||
| Stock | |||
| Debtors | -116,811 | -210,487 | 345,557 |
| Creditors | -61,788 | -75,647 | 269,711 |
| Accruals and Deferred Income | -108,498 | 119,375 | 1,819 |
| Deferred Taxes & Provisions | |||
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | |||
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | |||
| Group/Directors Accounts | |||
| Other Short Term Loans | |||
| Long term loans | |||
| Hire Purchase and Lease Commitments | |||
| other long term liabilities | |||
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | -409,717 | -833,460 | 1,255,743 |
| overdraft | |||
| change in cash | -409,717 | -833,460 | 1,255,743 |
singula bio ltd Credit Report and Business Information
Singula Bio Ltd Competitor Analysis
Perform a competitor analysis for singula bio ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in OX3 area or any other competitors across 12 key performance metrics.
singula bio ltd Ownership
SINGULA BIO LTD group structure
Singula Bio Ltd has no subsidiary companies.
Ultimate parent company
SINGULA BIO LTD
12792274
singula bio ltd directors
Singula Bio Ltd currently has 4 directors. The longest serving directors include Mr Ahmed Ahmed (Aug 2020) and Mr Joseph McVeigh (Aug 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Ahmed Ahmed | England | 55 years | Aug 2020 | - | Director |
| Mr Joseph McVeigh | United Kingdom | 60 years | Aug 2020 | - | Director |
| Mr John Bateson | Ireland | 61 years | Nov 2020 | - | Director |
| Dr James Hall | Sweden | 53 years | Mar 2021 | - | Director |
P&L
August 2023turnover
409.7k
+5%
operating profit
-369.2k
0%
gross margin
54.7%
-5.74%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2023net assets
-113.3k
-1.46%
total assets
31.7k
-0.94%
cash
12.6k
-0.97%
net assets
Total assets minus all liabilities
Similar Companies
singula bio ltd company details
company number
12792274
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
August 2020
age
5
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
August 2023
previous names
N/A
accountant
FINERVA
auditor
-
address
20 ambleside drive, headington, oxford, OX3 0AG
Bank
-
Legal Advisor
-
singula bio ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to singula bio ltd. Currently there are 1 open charges and 0 have been satisfied in the past.
singula bio ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SINGULA BIO LTD. This can take several minutes, an email will notify you when this has completed.
singula bio ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
